Tim Evans
Stock Analyst at Wells Fargo
(2.38)
# 2,495
Out of 4,761 analysts
23
Total ratings
72.73%
Success rate
4.35%
Average return
Main Sectors:
Stocks Rated by Tim Evans
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $290 → $280 | $312.05 | -10.27% | 2 | Feb 28, 2018 | |
| MEDP Medpace Holdings | Maintains: Market Perform | $38 → $35 | $340.22 | -89.71% | 3 | Feb 28, 2018 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $290 → $280 | $280.08 | -0.03% | 2 | Feb 28, 2018 | |
| ILMN Illumina | Upgrades: Outperform | n/a | $94.20 | - | 2 | Jan 2, 2018 | |
| WST West Pharmaceutical Services | Maintains: Outperform | $105 → $112 | $210.91 | -46.90% | 4 | Oct 27, 2017 | |
| DGX Quest Diagnostics | Maintains: Market Perform | $88 → $86 | $172.24 | -50.07% | 2 | Oct 20, 2017 | |
| LH Labcorp Holdings | Reinstates: Outperform | $175 | $249.85 | -29.96% | 1 | Oct 12, 2017 | |
| TECH Bio-Techne | Initiates: Market Perform | n/a | $64.92 | - | 1 | Jul 13, 2017 | |
| DHR Danaher | Initiates: Market Perform | $90 | $210.23 | -57.19% | 1 | Jul 13, 2017 | |
| MTD Mettler-Toledo International | Upgrades: Outperform | n/a | $1,286.54 | - | 1 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $50.82 | - | 2 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $135.37 | - | 1 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.64 | - | 1 | May 3, 2017 |
Bio-Rad Laboratories
Feb 28, 2018
Maintains: Outperform
Price Target: $290 → $280
Current: $312.05
Upside: -10.27%
Medpace Holdings
Feb 28, 2018
Maintains: Market Perform
Price Target: $38 → $35
Current: $340.22
Upside: -89.71%
Bio-Rad Laboratories
Feb 28, 2018
Maintains: Outperform
Price Target: $290 → $280
Current: $280.08
Upside: -0.03%
Illumina
Jan 2, 2018
Upgrades: Outperform
Price Target: n/a
Current: $94.20
Upside: -
West Pharmaceutical Services
Oct 27, 2017
Maintains: Outperform
Price Target: $105 → $112
Current: $210.91
Upside: -46.90%
Quest Diagnostics
Oct 20, 2017
Maintains: Market Perform
Price Target: $88 → $86
Current: $172.24
Upside: -50.07%
Labcorp Holdings
Oct 12, 2017
Reinstates: Outperform
Price Target: $175
Current: $249.85
Upside: -29.96%
Bio-Techne
Jul 13, 2017
Initiates: Market Perform
Price Target: n/a
Current: $64.92
Upside: -
Danaher
Jul 13, 2017
Initiates: Market Perform
Price Target: $90
Current: $210.23
Upside: -57.19%
Mettler-Toledo International
Jul 13, 2017
Upgrades: Outperform
Price Target: n/a
Current: $1,286.54
Upside: -
Jul 13, 2017
Downgrades: Underperform
Price Target: n/a
Current: $50.82
Upside: -
Jul 13, 2017
Upgrades: Outperform
Price Target: n/a
Current: $135.37
Upside: -
May 3, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $1.64
Upside: -